DarioHealth Corp. (ticker: DRIO) is an NASDAQ-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of DRIO's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 delisting/deregistration signal. DRIO reported $3.89M in revenue and -$8.25M for the period ending 2019-06-30, with operating cash flow of -$6.03M. Cash and equivalents stood at $14.98M (down 46.2% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
DRIO SEC Filings
Full cached SEC EDGAR filing history for DRIO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.